soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm and in Patients with Type 2 Diabetes FLOWing with the SemagluTIDE —

You will need to know the concentration of your specific medication vial

A study published in 2023 in the medical journal JAMA found that people who take these medications may be at an increased risk for pancreatitis (inflammation of the pancreas) and gastroparesis, sometimes called stomach paralysis because the stomach cant empty

While long-term research has been done on GLP-1 medications and Type 2 diabetes, Ashton said there is still much research to be done on how the medications can be used long-term to help people maintain weight loss

Alternatively, reconstitute with less water to create a higher concentration, letting you store more of the total supply in powder form until needed

Both formulations aim to provide flexibility in treatment options, catering to patient preferences and lifestyle